Works matching IS 00778923 AND DT 1996 AND VI 803 AND IP 1

Results: 39

Cellular Resistance to Camptothecins.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 60, doi. 10.1111/j.1749-6632.1996.tb26377.x
By:
- POMMIER, YVES;
- GUPTA, MALINI;
- VALENTI, MONICA;
- NIEVES-NEIRA, WILBERTO
Publication type:
Article
9-Aminocamptothecin and Beyond.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 231, doi. 10.1111/j.1749-6632.1996.tb26393.x
By:
- POTMESIL, MILAN;
- ARBUCK, SUSAN G.;
- TAKIMOTO, CHRIS H.;
- LIEBES, LEONARD;
- HOCHSTER, HOWARD
Publication type:
Article
CPT-11.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 282, doi. 10.1111/j.1749-6632.1996.tb26398.x
By:
- ARMAND, J. P.;
- TERRET, C.;
- COUTEAU, C.;
- RIXE, O.
Publication type:
Article
Synthesis of CPT-11 (Irinotecan Hydrochloride Trihydrate).
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 13, doi. 10.1111/j.1749-6632.1996.tb26372.x
By:
- SAWADA, S.;
- YOKOKURA, T.;
- MIYASAKA, T.
Publication type:
Article
The Cell Cycle Effects of Camptothecina.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 93, doi. 10.1111/j.1749-6632.1996.tb26379.x
By:
- DARZYNKIEWICZ, ZBIGNIEW;
- BRUNO, SILVIA;
- BINO, GIACINTA;
- TRAGANOS, FRANK
Publication type:
Article
Schedule-dependent Efficacy of Camptothecins in Models of Human Cancera.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 188, doi. 10.1111/j.1749-6632.1996.tb26388.x
By:
- HOUGHTON, PETER J.;
- STEWART, CLINTON F.;
- ZAMBONI, WILLIAM C.;
- THOMPSON, JOYCE;
- LUO, XIALOLONG;
- DANKS, MARY K.;
- HOUGHTON, JANET A.
Publication type:
Article
The Effect of Camptothecin on Topoisomerase I Catalysisa.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 50, doi. 10.1111/j.1749-6632.1996.tb26376.x
By:
- CHRISTIANSEN, KENT;
- WESTERGAARD, OLE
Publication type:
Article
Using Yeast to Understand Drugs that Target Topoisomerasesa.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 32, doi. 10.1111/j.1749-6632.1996.tb26374.x
By:
- NITISS, JOHN L.;
- ROSE, ANGELA;
- SYKES, KARIN C.;
- HARRIS, JAMES;
- ZHOU, JUNFANG
Publication type:
Article
Chemistry of the Camptothecins in the Bloodstream.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 29, doi. 10.1111/j.1749-6632.1996.tb26373.x
By:
- BURKE, THOMAS G.
Publication type:
Article
Radiation Enhancement by 9-Aminocamptothecin.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 312, doi. 10.1111/j.1749-6632.1996.tb26403.x
By:
- KIRICHENKO, A. V.;
- TRAVIS, E. L.;
- RICH, T. A.
Publication type:
Article
Pharmacokinetic and Pharmacodynamic Studies of 9-Aminocamptothecin in Vitro against Human Cancer Cells.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 315, doi. 10.1111/j.1749-6632.1996.tb26404.x
By:
- LI, M.;
- MOORE, M. J.;
- BERRY, B.;
- THIESSEN, J. J.
Publication type:
Article
Topoisomerase I Inhibition by the Camptothecin Analog G1147211C.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 202, doi. 10.1111/j.1749-6632.1996.tb26389.x
By:
- BESTERMAN, JEFFREY M.
Publication type:
Article
Camptothecin and Its Analogs.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 213, doi. 10.1111/j.1749-6632.1996.tb26391.x
By:
- MUGGIA, FRANCO M.;
- DIMERY, ISAIAH;
- ARBUCK, SUSAN G.
Publication type:
Article
Phase I Clinical and Pharmacological Studies of 20-(S)-Camptothecin and 20-(S)-9-Nitrocamptothecin as Anticancer Agents.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 224, doi. 10.1111/j.1749-6632.1996.tb26392.x
By:
- NATELSON, ETHAN A.;
- GIOVANELLA, BEPPINO C.;
- VERSCHRAEGEN, CLAIRE F.;
- FEHIR, KIM M.;
- IPOLYI, PETER D.;
- HARRIS, NICK;
- STEHLIN, JOHN S.
Publication type:
Article
Concluding Remarks.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 327, doi. 10.1111/j.1749-6632.1996.tb26408.x
By:
- GIOVANELLA, BEPPWO C.
Publication type:
Article
Induction of Apoptosis in Malignant and Camptothecin-resistant Human Cellsa.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 143, doi. 10.1111/j.1749-6632.1996.tb26383.x
By:
- CHATTERJEE, DEVASIS;
- WYCHE, JAMES H.;
- PANTAZIS, PANAYOTIS
Publication type:
Article
Clinical Studies of Topotecan.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 264, doi. 10.1111/j.1749-6632.1996.tb26396.x
By:
- BROOM, COLIN
Publication type:
Article
Clinical Trials of Irinotecan Hydrochloride (CPT, Campto Injection, Topotecin Injection) in Japana.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 292, doi. 10.1111/j.1749-6632.1996.tb26399.x
By:
- SAIJO, NAGAHIRO
Publication type:
Article
Introduction and Overview.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. ix, doi. 10.1111/j.1749-6632.1996.tb26370.x
By:
- STEHLIN, JOHN S.
Publication type:
Article
Second Generation Synthesis of (20S)-Camptothecin and Derivatives via a Cascade Radical Reaction.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 310, doi. 10.1111/j.1749-6632.1996.tb26402.x
By:
- CURRAN, DENNIS P.;
- JOSIEN, HUBERT;
- KO, SUNG-BO
Publication type:
Article
Lowered Phosphorylation of Topoisomerase I Is a Direct Reason for Reduced Sensitivity of L5178Y-S Cells to Camptothecin.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 321, doi. 10.1111/j.1749-6632.1996.tb26406.x
By:
- STARON, KRZYSZTOF;
- KOWALSKA-LOTH, BARBARA;
- SZUMIEL, IRENA
Publication type:
Article
Implications for the Use of Topoisomerase I Inhibitors in Treatment of Patients with Systemic Sclerosisa.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 318, doi. 10.1111/j.1749-6632.1996.tb26405.x
By:
- RUDNICKA, LIDIA;
- CZUWARA, JOANNA;
- BARUSIŃSKA, AGNIESZKA;
- NOWICKA, URSZULA;
- MAKIELA, BARBARA;
- JABLONSKA, STEFANIA
Publication type:
Article
Failure in DNA Elongation Predicts Sensitivity to Camptothecin in the Colon Cell Lines of the NCI Anticancer Drug Screen.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 308, doi. 10.1111/j.1749-6632.1996.tb26401.x
By:
- GOLDWASSER, FRANCOIS;
- SHIMIZU, TSUNEHIRO;
- POMMIER, YVES
Publication type:
Article
Topoisomerase-I Inhibitors in the Management of Colon Cancer.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 256, doi. 10.1111/j.1749-6632.1996.tb26395.x
By:
- WILLSON, JAMES K. V.
Publication type:
Article
Clinical Pharmacology and Pharmacodynamics of Irinotecan.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 164, doi. 10.1111/j.1749-6632.1996.tb26385.x
By:
- CHABOT, GUY G.
Publication type:
Article
Pharmacokinetics of Camptothecins Administered Orallya.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 157, doi. 10.1111/j.1749-6632.1996.tb26384.x
By:
- LIEHR, JOACHIM G.;
- AHMED, AHMED E.;
- GIOVANELLA, BEPPINO C.
Publication type:
Article
Factors Affecting Topotecan Sensitivity in Human Leukemia Samplesa.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 128, doi. 10.1111/j.1749-6632.1996.tb26382.x
By:
- KAUFMANN, SCOTT H.;
- GORE, STEVEN D.;
- LETENDRE, LOUIS;
- SVINGEN, PHYLLIS A.;
- KOTTKE, TIMOTHY;
- BUCKWALTER, CHRISTOPHER A.;
- JONES, RICHARD J.;
- GROCHOW, LOUISE B.;
- BURKE, PHILIP J.;
- DONEHOWER, ROSS C.;
- ROWINSKY, ERIC K.
Publication type:
Article
Camptothecin Resistance Related to Drug-induced Down-Regulation of Topoisomerase I and to Steps Occurring after the Formation of Protein-linked DNA Breaksa.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 74, doi. 10.1111/j.1749-6632.1996.tb26378.x
By:
- MURREN, JOHN R.;
- BEIDLER, DAVID R.;
- CHENG, YUNG CHI
Publication type:
Article
Induction of Apoptosis by Camptothecin and Topotecan.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 101, doi. 10.1111/j.1749-6632.1996.tb26380.x
By:
- TRAGANOS, FRANK;
- SEITER, KAREN;
- FELDMAN, ERIC;
- HALICKA, H. DOROTA;
- DARZYNKIEWICZ, ZBIGNIEW
Publication type:
Article
Protocols for the Treatment of Human Tumor Xenografts with Camptothecins.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 181, doi. 10.1111/j.1749-6632.1996.tb26387.x
By:
- GIOVANELLA, B. C.;
- NATELSON, E.;
- HARRIS, N.;
- VARDEMAN, D.;
- STEHLIN, J. S.
Publication type:
Article
Mechanism of Action of Camptothecin.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 44, doi. 10.1111/j.1749-6632.1996.tb26375.x
By:
- Liu, Leroy F.;
- Duann, Pu;
- Lin, Ching-Tai;
- D'Arpa, Peter;
- Wu, Jiaxi
Publication type:
Article
Discovery to Clinica.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 1, doi. 10.1111/j.1749-6632.1996.tb26371.x
By:
- WALL, MONROE E.;
- WANI, MANSUKH C.
Publication type:
Article
Treatment of Central Nervous System Xenografts with Camptothecins.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 210, doi. 10.1111/j.1749-6632.1996.tb26390.x
By:
- FRIEDMAN, HENRY S.;
- HOUGHTON, PETER J.
Publication type:
Article
Clinical Pharmacology of 9-Aminocamptothecin.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 324, doi. 10.1111/j.1749-6632.1996.tb26407.x
By:
- TAKIMOTO, CHRIS H.;
- DAHUT, WILLIAM;
- HAROLD, NANCY;
- NAKASHIMA, HAJIME;
- LIEBERMAN, RONALD;
- LIANG, MICHAEL D.;
- ARBUCK, SUSAN G.;
- CHEN, ALICE P.;
- HAMILTON, J. MICHAEL;
- CANTILENA, LOUIS R.;
- ALLEGRA, CARMEN J.;
- GREM, JEAN L.
Publication type:
Article
Cytotoxic Efficacy with Combinations of Topoisomerase I and Topoisomerase II Inhibitors in Sensitive and Multidrugresistant L1210 Mouse Leukemia Cellsa.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 306, doi. 10.1111/j.1749-6632.1996.tb26400.x
By:
- GRABOWSKI, DALE;
- GANAPATHI, RAM
Publication type:
Article
The Current Status of Irinotecan (CPT-11) in the United States.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 272, doi. 10.1111/j.1749-6632.1996.tb26397.x
By:
- ROTHENBERG, MACE L.
Publication type:
Article
Identification of Topoisomerase I Mutations Affecting Both DNA Cleavage and Interaction with Camptothecina.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 111, doi. 10.1111/j.1749-6632.1996.tb26381.x
By:
- LI, XI-GUANG;
- HALUSKA, PAUL;
- HSIANG, YAW-HUEI;
- BHARTI, AJIT;
- KUFE, DONALD W.;
- RUBIN, ERIC H.
Publication type:
Article
Trials of 9-Amino-20(S)-Camptothecin in Boston.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 247, doi. 10.1111/j.1749-6632.1996.tb26394.x
By:
- EDER, JOSEPH P.;
- RUBIN, ERIC;
- STONE, RICHARD;
- BRYANT, MARGARET;
- XU, GUANXIAN;
- SUPKO, JEFFREY;
- KINCHLA, NANCY;
- LYNCH, THOMAS;
- HURWITZ, SELWYN;
- RODRIGUEZ, DEE;
- SHAPIRO, CHARLES;
- TOPPMEYER, DEBORAH;
- GROSSBARD, MICHAEL;
- VOSBURG, EVAN;
- HUBERMAN, MARK;
- SCHNIPPER, LOWELL;
- SHULMAN, LAWRENCE;
- KUFE, DONALD W.
Publication type:
Article
Preclinical Antitumor Activity and Pharmacokinetics of Irinotecan (CPT-11) in Tumor-bearing Mice.
Published in:
Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 173, doi. 10.1111/j.1749-6632.1996.tb26386.x
By:
- BISSERY, MARIE-CHRISTINE;
- VRIGNAUD, PATRICIA;
- LAVELLE, FRANCOIS;
- CHABOT, GUY G.
Publication type:
Article

Works matching IS 00778923 AND DT 1996 AND VI 803 AND IP 1

Cellular Resistance to Camptothecins.

9-Aminocamptothecin and Beyond.

CPT-11.

Synthesis of CPT-11 (Irinotecan Hydrochloride Trihydrate).

The Cell Cycle Effects of Camptothecin<sup>a</sup>.

Schedule-dependent Efficacy of Camptothecins in Models of Human Cancer<sup>a</sup>.

The Effect of Camptothecin on Topoisomerase I Catalysis<sup>a</sup>.

Using Yeast to Understand Drugs that Target Topoisomerases<sup>a</sup>.

Chemistry of the Camptothecins in the Bloodstream.

Radiation Enhancement by 9-Aminocamptothecin.

Pharmacokinetic and Pharmacodynamic Studies of 9-Aminocamptothecin in Vitro against Human Cancer Cells.

Topoisomerase I Inhibition by the Camptothecin Analog G1147211C.

Camptothecin and Its Analogs.

Phase I Clinical and Pharmacological Studies of 20-(S)-Camptothecin and 20-(S)-9-Nitrocamptothecin as Anticancer Agents.

Concluding Remarks.

Induction of Apoptosis in Malignant and Camptothecin-resistant Human Cells<sup>a</sup>.

Clinical Studies of Topotecan.

Clinical Trials of Irinotecan Hydrochloride (CPT, Campto Injection, Topotecin Injection) in Japan<sup>a</sup>.

Introduction and Overview.

Second Generation Synthesis of (20S)-Camptothecin and Derivatives via a Cascade Radical Reaction.

Lowered Phosphorylation of Topoisomerase I Is a Direct Reason for Reduced Sensitivity of L5178Y-S Cells to Camptothecin.

Implications for the Use of Topoisomerase I Inhibitors in Treatment of Patients with Systemic Sclerosis<sup>a</sup>.

Failure in DNA Elongation Predicts Sensitivity to Camptothecin in the Colon Cell Lines of the NCI Anticancer Drug Screen.

Topoisomerase-I Inhibitors in the Management of Colon Cancer.

Clinical Pharmacology and Pharmacodynamics of Irinotecan.

Pharmacokinetics of Camptothecins Administered Orally<sup>a</sup>.

Factors Affecting Topotecan Sensitivity in Human Leukemia Samples<sup>a</sup>.

Camptothecin Resistance Related to Drug-induced Down-Regulation of Topoisomerase I and to Steps Occurring after the Formation of Protein-linked DNA Breaks<sup>a</sup>.

Induction of Apoptosis by Camptothecin and Topotecan.

Protocols for the Treatment of Human Tumor Xenografts with Camptothecins.

Mechanism of Action of Camptothecin.

Discovery to Clinic<sup>a</sup>.

Treatment of Central Nervous System Xenografts with Camptothecins.

Clinical Pharmacology of 9-Aminocamptothecin.

Cytotoxic Efficacy with Combinations of Topoisomerase I and Topoisomerase II Inhibitors in Sensitive and Multidrugresistant L1210 Mouse Leukemia Cells<sup>a</sup>.

The Current Status of Irinotecan (CPT-11) in the United States.

Identification of Topoisomerase I Mutations Affecting Both DNA Cleavage and Interaction with Camptothecin<sup>a</sup>.

Trials of 9-Amino-20(S)-Camptothecin in Boston.

Preclinical Antitumor Activity and Pharmacokinetics of Irinotecan (CPT-11) in Tumor-bearing Mice.